Khyati Maulik Kariya, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mitochondria | 8 | 2019 | 3672 | 0.700 |
Why?
|
| Lysosomes | 4 | 2019 | 932 | 0.510 |
Why?
|
| Mitochondrial Proteins | 2 | 2018 | 975 | 0.360 |
Why?
|
| Erythromycin | 1 | 2019 | 114 | 0.320 |
Why?
|
| Clindamycin | 1 | 2019 | 138 | 0.320 |
Why?
|
| Apoptosis | 4 | 2019 | 9508 | 0.290 |
Why?
|
| MicroRNAs | 3 | 2017 | 3787 | 0.260 |
Why?
|
| Autophagy | 3 | 2019 | 1349 | 0.260 |
Why?
|
| Interferon Regulatory Factor-3 | 1 | 2017 | 145 | 0.260 |
Why?
|
| Caspase 3 | 1 | 2018 | 731 | 0.250 |
Why?
|
| Lymphoma, T-Cell | 2 | 2025 | 308 | 0.250 |
Why?
|
| Oxidants | 1 | 2015 | 167 | 0.240 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2015 | 4342 | 0.240 |
Why?
|
| Membrane Proteins | 3 | 2017 | 7850 | 0.230 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2015 | 2795 | 0.220 |
Why?
|
| Electron Transport Complex I | 1 | 2014 | 150 | 0.220 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2017 | 1043 | 0.200 |
Why?
|
| Hydrogen Peroxide | 1 | 2015 | 740 | 0.190 |
Why?
|
| Parkinson Disease | 2 | 2017 | 2885 | 0.190 |
Why?
|
| NF-kappa B | 3 | 2017 | 2495 | 0.190 |
Why?
|
| Toll-Like Receptors | 1 | 2014 | 582 | 0.180 |
Why?
|
| Lectins, C-Type | 1 | 2024 | 592 | 0.180 |
Why?
|
| Stress, Physiological | 1 | 2017 | 1405 | 0.170 |
Why?
|
| RNA-Binding Proteins | 1 | 2018 | 1883 | 0.160 |
Why?
|
| Breast Neoplasms | 4 | 2017 | 21074 | 0.150 |
Why?
|
| DNA Damage | 1 | 2018 | 2463 | 0.150 |
Why?
|
| Translocation, Genetic | 1 | 2024 | 1393 | 0.150 |
Why?
|
| Receptors, Immunologic | 1 | 2024 | 1416 | 0.150 |
Why?
|
| Membrane Fusion | 2 | 2019 | 264 | 0.140 |
Why?
|
| Nerve Tissue Proteins | 1 | 2018 | 4399 | 0.120 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2015 | 2898 | 0.120 |
Why?
|
| Carrier Proteins | 1 | 2018 | 4910 | 0.120 |
Why?
|
| Cell Line, Tumor | 6 | 2024 | 17071 | 0.120 |
Why?
|
| Reactive Oxygen Species | 3 | 2019 | 2144 | 0.120 |
Why?
|
| Oxidative Stress | 1 | 2015 | 3140 | 0.110 |
Why?
|
| HEK293 Cells | 3 | 2018 | 4263 | 0.110 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2024 | 1433 | 0.110 |
Why?
|
| Cell Survival | 3 | 2018 | 5747 | 0.100 |
Why?
|
| Neoplasm Proteins | 1 | 2014 | 3594 | 0.100 |
Why?
|
| HeLa Cells | 2 | 2018 | 3073 | 0.100 |
Why?
|
| Protein Transport | 2 | 2018 | 1939 | 0.090 |
Why?
|
| Ribosome Subunits, Large, Bacterial | 1 | 2019 | 5 | 0.080 |
Why?
|
| Inflammation | 2 | 2017 | 10860 | 0.080 |
Why?
|
| Mice, Nude | 2 | 2017 | 3610 | 0.080 |
Why?
|
| Adenosine Triphosphate | 2 | 2015 | 2003 | 0.080 |
Why?
|
| X-Linked Inhibitor of Apoptosis Protein | 1 | 2018 | 62 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2015 | 4565 | 0.070 |
Why?
|
| Oxidopamine | 1 | 2017 | 169 | 0.070 |
Why?
|
| Blotting, Western | 2 | 2015 | 5020 | 0.070 |
Why?
|
| Transcytosis | 1 | 2017 | 48 | 0.070 |
Why?
|
| Electron Transport Chain Complex Proteins | 1 | 2015 | 39 | 0.060 |
Why?
|
| Amino Acid Chloromethyl Ketones | 1 | 2014 | 68 | 0.060 |
Why?
|
| Cytochromes c | 1 | 2015 | 173 | 0.060 |
Why?
|
| Rotenone | 1 | 2015 | 50 | 0.060 |
Why?
|
| Cell Proliferation | 3 | 2015 | 10433 | 0.060 |
Why?
|
| Lymphoma, Extranodal NK-T-Cell | 1 | 2025 | 52 | 0.060 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2015 | 292 | 0.060 |
Why?
|
| Caspase 8 | 1 | 2015 | 198 | 0.060 |
Why?
|
| Free Radical Scavengers | 1 | 2014 | 213 | 0.060 |
Why?
|
| Acetylcysteine | 1 | 2014 | 262 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-bcl-6 | 1 | 2024 | 190 | 0.050 |
Why?
|
| Immunoprecipitation | 1 | 2015 | 874 | 0.050 |
Why?
|
| Cell Line | 2 | 2019 | 15546 | 0.050 |
Why?
|
| 5' Untranslated Regions | 1 | 2024 | 255 | 0.050 |
Why?
|
| Cell Movement | 2 | 2015 | 5196 | 0.050 |
Why?
|
| Models, Biological | 2 | 2019 | 9445 | 0.050 |
Why?
|
| Clone Cells | 1 | 2015 | 1671 | 0.050 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2015 | 2469 | 0.050 |
Why?
|
| Protease Inhibitors | 1 | 2014 | 750 | 0.050 |
Why?
|
| Ubiquitination | 1 | 2015 | 1000 | 0.050 |
Why?
|
| Ubiquitin | 1 | 2015 | 840 | 0.040 |
Why?
|
| Caspases | 1 | 2013 | 881 | 0.040 |
Why?
|
| Chemokines | 1 | 2014 | 959 | 0.040 |
Why?
|
| Sirolimus | 1 | 2017 | 1541 | 0.040 |
Why?
|
| Humans | 14 | 2025 | 766117 | 0.040 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2017 | 8612 | 0.040 |
Why?
|
| Cell Death | 1 | 2014 | 1676 | 0.040 |
Why?
|
| Enzyme Activation | 1 | 2015 | 3584 | 0.040 |
Why?
|
| Gene Rearrangement | 1 | 2024 | 1143 | 0.040 |
Why?
|
| Cell Nucleus | 1 | 2017 | 2864 | 0.040 |
Why?
|
| Energy Metabolism | 1 | 2018 | 2894 | 0.030 |
Why?
|
| Neoplasms | 1 | 2015 | 22344 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2024 | 3604 | 0.030 |
Why?
|
| Killer Cells, Natural | 1 | 2024 | 2206 | 0.030 |
Why?
|
| Immunity, Innate | 1 | 2017 | 3079 | 0.030 |
Why?
|
| Signal Transduction | 2 | 2017 | 23605 | 0.030 |
Why?
|
| Animals | 4 | 2024 | 168800 | 0.030 |
Why?
|
| Protein Binding | 1 | 2015 | 9301 | 0.030 |
Why?
|
| Proteomics | 1 | 2015 | 3907 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2019 | 7474 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2015 | 12775 | 0.020 |
Why?
|
| B-Lymphocytes | 1 | 2024 | 4782 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2018 | 11906 | 0.020 |
Why?
|
| DNA | 1 | 2024 | 7193 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2013 | 11035 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2014 | 9354 | 0.020 |
Why?
|
| Neurons | 1 | 2017 | 9521 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 2024 | 9237 | 0.020 |
Why?
|
| Mice | 2 | 2024 | 81839 | 0.020 |
Why?
|
| Female | 4 | 2025 | 396233 | 0.020 |
Why?
|
| Prognosis | 1 | 2025 | 29912 | 0.010 |
Why?
|
| Young Adult | 1 | 2025 | 59868 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2025 | 65219 | 0.010 |
Why?
|
| Adolescent | 1 | 2025 | 88819 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2025 | 81565 | 0.010 |
Why?
|
| Aged | 1 | 2025 | 171219 | 0.010 |
Why?
|
| Middle Aged | 1 | 2025 | 223083 | 0.010 |
Why?
|
| Adult | 1 | 2025 | 223139 | 0.010 |
Why?
|
| Male | 1 | 2025 | 363935 | 0.000 |
Why?
|